135 related articles for article (PubMed ID: 2890665)
1. The acute and chronic effects of betaxolol on blood pressure, renin-aldosterone, and renal function in essential hypertension.
Reams GP; Bauer JH; Lau A
J Clin Pharmacol; 1987 Feb; 27(2):118-21. PubMed ID: 2890665
[TBL] [Abstract][Full Text] [Related]
2. A comparison of betaxolol and nadolol on renal function in essential hypertension.
Bauer JH; Reams GP; Lau A
Am J Kidney Dis; 1987 Aug; 10(2):109-12. PubMed ID: 3300292
[TBL] [Abstract][Full Text] [Related]
3. Long term treatment of moderate hypertension with penbutolol (Hoe 893d). I. Effects on blood pressure, pulse rate, catecholamines in blood and urine, plasma renin activity and urinary aldosterone under basal conditions and following exercise.
Hansson BG; Hökfelt B
Eur J Clin Pharmacol; 1975 Oct; 9(1):9-19. PubMed ID: 9298
[TBL] [Abstract][Full Text] [Related]
4. Influence of treatment by betaxolol on the renal response to postural changes in moderate hypertension.
Madonna O; Labeeuw M; Pozet N; Aissa AH; Zech P
Int J Clin Pharmacol Ther Toxicol; 1988 Mar; 26(3):133-7. PubMed ID: 3410595
[TBL] [Abstract][Full Text] [Related]
5. Betaxolol. A new beta-adrenergic blocking agent for treatment of glaucoma.
Berrospi AR; Leibowitz HM
Arch Ophthalmol; 1982 Jun; 100(6):943-6. PubMed ID: 6124227
[TBL] [Abstract][Full Text] [Related]
6. [The renin-aldosterone system in essential hypertension--hypotensive action of beta adrenergic blocking agents and variation of the renin-aldosterone system (author's transl)].
Hata S
Nihon Naibunpi Gakkai Zasshi; 1977 Oct; 53(10):1129-39. PubMed ID: 22466
[TBL] [Abstract][Full Text] [Related]
7. Renin and beta-blockade: prorenin and aldosterone may explain the controversy.
McKenna F; Davison AM
Clin Nephrol; 1986 Mar; 25(3):149-54. PubMed ID: 2869848
[TBL] [Abstract][Full Text] [Related]
8. Comparison of betaxolol, a new beta 1-adrenergic antagonist, to propranolol in the treatment of mild to moderate hypertension.
Davidov ME; Glazer N; Wollam G; Zager PG; Cangiano J
Am J Hypertens; 1988 Jul; 1(3 Pt 3):206S-210S. PubMed ID: 2901266
[TBL] [Abstract][Full Text] [Related]
9. Medium-term effects of betaxolol monotherapy and combination therapy with nitrendipine on lipoprotein and apolipoprotein metabolism in patients with mild to moderate essential hypertension.
Saku K; Zhang B; Okamoto T; Takeda Y; Liu K; Jimi S; Arakawa K
J Hum Hypertens; 1996 Apr; 10(4):263-8. PubMed ID: 8736459
[TBL] [Abstract][Full Text] [Related]
10. Plasma renin activity and angiotensin I and aldosterone concentrations in cats with hypertension associated with chronic renal disease.
Jensen J; Henik RA; Brownfield M; Armstrong J
Am J Vet Res; 1997 May; 58(5):535-40. PubMed ID: 9140564
[TBL] [Abstract][Full Text] [Related]
11. [Betaxolol versus nifedipine in the treatment of essential hypertension].
Steiner A; Hany S; Bättig B; Jenni R; Troesch M; Willimann P; Graf A; Leutenegger F; Angehrn V; Beck G
Schweiz Rundsch Med Prax; 1988 Oct; 77(41):1101-3. PubMed ID: 2907178
[No Abstract] [Full Text] [Related]
12. Long term non-selective and cardioselective beta-receptor blockade in hypertensive patients. Effects on circulatory parameters, catecholamines and renin activity under basal conditions and in connection with exercise and hypoglycemia.
Hansson BG
Acta Med Scand Suppl; 1976; 598():1-61. PubMed ID: 13611
[No Abstract] [Full Text] [Related]
13. Renin in essential hypertension.
Atlas SA; Case DB
Clin Endocrinol Metab; 1981 Nov; 10(3):537-75. PubMed ID: 6124330
[No Abstract] [Full Text] [Related]
14. Betaxolol. A review of its pharmacodynamic and pharmacokinetic properties, and therapeutic efficacy in hypertension.
Beresford R; Heel RC
Drugs; 1986 Jan; 31(1):6-28. PubMed ID: 2866947
[TBL] [Abstract][Full Text] [Related]
15. The effect of triple drug therapy on renal function in patients with essential hypertension.
Reams GP; Bauer JH
J Clin Pharmacol; 1989 Sep; 29(9):803-8. PubMed ID: 2572610
[TBL] [Abstract][Full Text] [Related]
16. Effects of carvedilol on renal function.
Dupont AG
Eur J Clin Pharmacol; 1990; 38 Suppl 2():S96-100. PubMed ID: 1974513
[TBL] [Abstract][Full Text] [Related]
17. Influence of antihypertensive medication on aldosterone and renin concentration in the differential diagnosis of essential hypertension and primary aldosteronism.
Seifarth C; Trenkel S; Schobel H; Hahn EG; Hensen J
Clin Endocrinol (Oxf); 2002 Oct; 57(4):457-65. PubMed ID: 12354127
[TBL] [Abstract][Full Text] [Related]
18. [Effect of different beta-receptor blockers on the respiratory function of patients with chronic obstructive pulmonary disease and arterial hypertension].
Dorow P
Arzneimittelforschung; 1987 Dec; 37(12):1370-2. PubMed ID: 2896506
[TBL] [Abstract][Full Text] [Related]
19. [Effect of chronic beta-adrenergic blockade on blood pressure and release of renin, aldosterone and cortisol in essential hypertension (author's transl)].
Stumpe KO; Vetter H; Hessenbruch V; Düsing R; Kolloch R; Krück F
Klin Wochenschr; 1975 Oct; 53(19):907-11. PubMed ID: 241876
[TBL] [Abstract][Full Text] [Related]
20. Bopindolol: long-term effects on blood pressure, renal function, plasma renin activity, and plasma aldosterone in mild-to-moderate essential hypertension.
Shohat J; Modan M; Rosenfeld JB
Fundam Clin Pharmacol; 1989; 3(1):53-8. PubMed ID: 2565862
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
